<prompt> Fingqa isihloko: I-Food and Drug Administration igcina isexwayiso esibhalwe ngolimi oluqinile emuthini we-Pfizer wokulwa nokubhema i-Chantix mayelana nokuziphatha kokuzibulala neminye imiphumela emibi yengqondo, ngemuva kokubuyekeza okutholakele kwenkampani okusikisela ukuthi lo muthi awubhebhethekisi lezo zinkinga. I-tablet esetshenziswa kabili ngosuku ibilokhu inelebula eliyisixwayiso eliqinile le-FDA kusukela ngo-2009, kulandela imibiko yokuthambekela kokuzibulala nokuziphatha okunobudlova noma okungajwayelekile kwezinye iziguli. I-FDA ngoMsombuluko yaveza izibuyekezo eziningana ekubekweni kwelebuli yeChantix, kuhlanganise nesixwayiso esisha mayelana nokusebenzisana kwayo notshwala. Ezinye iziguli ziye zabika ukuziphatha okungavamile noma okunobudlova lapho ziphuza ngenkathi zithatha i-Chantix. Qaphela: Umuthi wokulwa nokubhema i-Chantix ubelokhu uphethe ilebula eliyisixwayiso eliqinile le-FDA kusukela ngo-2009, kulandela imibiko yokuthambekela kokuzibulala nokuziphatha okunobudlova noma okungajwayelekile phakathi kwezinye iziguli. I-U.S. Food and Drug Administration FDA ixwayisa ngokuthi umuthi wokunqanda ukubhema i-Chantix i-varenicline ungashintsha indlela abantu abasabela ngayo otshwaleni, kusho le nhlangano. Ngaphezu kwalokho, kuye kwabikwa izindaba ezingavamile zokuquleka ezigulini ezilashwa ngeChantix. Siye savuma ukuba kushintshwe ilebula le-Chantix ukuze kuxwayiswe ngalezi zingozi. Kuze kube yilapho iziguli ziyazi ukuthi i- Chantix ilithinta kanjani ikhono lazo lokubekezelela utshwala, kufanele zinciphise inani lotshwala ezibuphuzayo. Iziguli ezihlaselwa yisifo sokuwa lapho zithatha i- Chantix kufanele ziyeke ukuthatha lo muthi futhi zifune usizo lodokotela ngokushesha. Ukubekwa uphawu okusha kuhlanganisa nolwazi oluvela ezifundweni eziningi nasekuhlaziyweni okwenziwa yi-Pfizer okungatholanga mehluko ezinkingeni zengqondo phakathi kwabantu abathatha i-Chantix nezinye izindlela zokwelapha ukuyeka ukubhema. I-FDA yathi:Lezi zifundo azibonisanga ingozi eyengeziwe yemiphumela emibi ye- neuropsychiatric nge- Chantix; kodwa-ke, azizange zihlole zonke izinhlobo zemiphumela emibi ye- neuropsychiatric, futhi zazinemikhawulo eyayisivimbela ekutholeni iziphetho ezinokwethenjelwa. Ngonyaka odlule i-Pfizer yaphakamisa ukuthi i-FDA isuse lokho okubizwa ngokuthi isixwayiso sebhokisi elimnyama le-Chantix ngokusekelwe kulokho okutholwe yinkampani nokunye...  <response>: I - FDA igcina isixwayiso esibhalwe ngokugqamile emuthini we - Pfizer wokulwa nokubhema i - Chantix mayelana nokuziphatha kokuzibulala neminye imiphumela emibi yengqondo. Leli thebhulethi linelebula eliyisixwayiso eliqine kunazo zonke le-FDA kusukela ngo-2009. Lokhu kulandela imibiko yokuthambekela kokuzibulala nokuziphatha okunobudlova noma okungajwayelekile kwezinye iziguli. I-FDA ngoMsombuluko yaveza izibuyekezo eziningana ekubekweni kwelebuli yeChantix, kuhlanganise nesixwayiso esisha mayelana nokusebenzisana kwayo notshwala. Ezinye iziguli ziye zabika ngokuziphatha okungavamile noma okunobudlova lapho ziphuza ngenkathi zithatha iChantix. 